Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes (Q35147560)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes |
scientific article |
Statements
1 reference
Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes (English)
1 reference
Kevan C Herold
1 reference
Mark D Pescovitz
1 reference
Paula McGee
1 reference
Heidi Krause-Steinrauf
1 reference
Lisa M Spain
1 reference
Kasia Bourcier
1 reference
Adam Asare
1 reference
Zhugong Liu
1 reference
H Michael Dosch
1 reference
Type 1 Diabetes TrialNet Anti-CD20 Study Group
1 reference
20 July 2011
1 reference
1 reference
187
1 reference
4
1 reference
1998-2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference